- We will send in 10–14 business days.
/images/books/11288384/9781588299154.jpg)
- Publisher: Humana Press
- Year: 2008
- Pages: 274
- ISBN-10: 1588299155
- ISBN-13: 9781588299154
- Format: 16.2 x 23.6 x 1.9 cm, hardcover
- Language: English
- SAVE -10% with code: EXTRA
New Antibiotic Targets (e-book) (used book) | bookbook.eu
Reviews
Description
A crisis is developing in the treatment of infectious diseases, with microorganisms frequently showing resistance to currently prescribed antibiotics. Fewer and fewer antimicrobial agents are now available to treat these infections. In "New Antibiotic Targets," W. Scott Champney examines specific techniques which can be used to explore new drug targets and the effectiveness of new antibiotics. By testing new antimicrobial agents and modified existing drugs, the most vulnerable cell processes, such as cell wall and membrane synthesis, DNA replication, RNA transcription and protein synthesis, can be better exploited. This in-depth volume, however, delves even deeper by identifying additional novel cellular targets for these new therapies.
"New Antibiotic Targets" provides laboratory investigators with the vital tools they need to test the antimicrobial potential of products and to curb the rise of so many infectious diseases.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 20d.18:43:43
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Publisher: Humana Press
- Year: 2008
- Pages: 274
- ISBN-10: 1588299155
- ISBN-13: 9781588299154
- Format: 16.2 x 23.6 x 1.9 cm, hardcover
- Language: English English
A crisis is developing in the treatment of infectious diseases, with microorganisms frequently showing resistance to currently prescribed antibiotics. Fewer and fewer antimicrobial agents are now available to treat these infections. In "New Antibiotic Targets," W. Scott Champney examines specific techniques which can be used to explore new drug targets and the effectiveness of new antibiotics. By testing new antimicrobial agents and modified existing drugs, the most vulnerable cell processes, such as cell wall and membrane synthesis, DNA replication, RNA transcription and protein synthesis, can be better exploited. This in-depth volume, however, delves even deeper by identifying additional novel cellular targets for these new therapies.
"New Antibiotic Targets" provides laboratory investigators with the vital tools they need to test the antimicrobial potential of products and to curb the rise of so many infectious diseases.
Reviews